
Linklaters announced the election of two new partners in its global antitrust group, effective May 1, 2021.
Charlotte Colin-Dubuisson has been elected as partner in the firm’s Paris office. Charlotte joined Linklaters in 2011 and has extensive expertise in key areas of competition law with a focus on high-profile antitrust investigations and global merger control matters. She advises both on European and French Competition law with specific expertise in the FMCG, automotive, transport, optical retail, and healthcare sectors.
Xi Liao has been elected as partner at Zhao Sheng Law Firm, the firm’s joint operation partner in the People’s Republic of China. Xi is based in Beijing and has represented a number of multinational and Chinese companies and investment funds on various aspects of competition law including handing merger filings, responding to investigations, devising compliance programs, and providing behavioral counseling. Xi has extensive experience in multiple sectors including healthcare, natural resources & energy, technology, transport & infrastructure, chemicals, and FMCG.
Christian Ahlborn, global head of the Antitrust & Foreign Investment Group at Linklaters, said, “These promotions are testament to the strength of our global practice at a time when antitrust and foreign investment issues are becoming ever more critical for our clients. Congratulations to them all.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas